IL6 and Parkinson disease: This leads to the production of proinflammatory cytokines (e.g., TNF-α, IL-1β, IL-6) and enzymes (e.g., nicotinamide adenine dinucleotide phosphate oxidase and cyclooxygenase-2) that affect the central nervous system microenvironment, speeding up PD pathogenesis [28].